The CFA Institute is calling out the lack of clarity and standardization around environmental, social and governance investment products. In a consultation paper, the organization proposed its own set of standards, welcoming industry stakeholders to weigh in. As interest in ESG products continues to grow from both retail and institutional investors, confusion remains about the […]
Quebec is applying new pension relief measures and is also extending the credit on employer contributions to the health services fund. The pension relief measures, which the federal government announced in early July, will allow registered pension plans to borrow money and extend the deadline to retroactively credit pensionable service under a defined benefit plan. […]
For defined contribution plan members who were intending to retire in the first half of 2020, the market crash caused by the coronavirus may have upended those plans. Markets reached a trough in March, followed by some recovery, but with little clarity on what investments will do next, it’s a challenging time for plan members […]
In its submission to the Patented Medicine Prices Review Board’s draft guidelines, the Canadian Life and Health Insurance Association is suggesting that the board consider disbursing excess revenues from pharmaceutical companies to employers rather than just to the provincial and territorial public payers. Currently, any excess revenues — determined by voluntary compliance undertaking or orders […]
Prime Minister Justin Trudeau says the government plans to move out-of-work Canadians into the employment insurance system and provide parallel support for millions set to exhaust emergency pandemic aid who don’t have EI to fall back on. The $80-billion Canada Emergency Response Benefit is set to wind down over the coming weeks, with those who […]
The federal government is easing eligibility rules for the government’s emergency wage subsidy and changing the amounts businesses can receive. The government had been under pressure to make the subsidy more accessible, specifically by loosening the requirement of a 30 per cent drop in revenues, so more companies under that cut-off can qualify. Speaking in Toronto […]
The Federal Court has upheld reforms to the Patented Medicines Pricing Review Board that updated the board’s reference countries for drug pricing and required it to review three new economic factors when determining whether patented medicines are excessively priced. The court ruled against an argument by Innovative Medicines Canada and 16 pharmaceutical companies in their […]
While 67 per cent of Canadian plan members described their level of knowledge about a possible national pharmacare program as low or medium, 27 per cent said they don’t know anything at all about it, according to the 2020 Sanofi Canada health-care survey. Among plan sponsor respondents, 73 per cent described their level of knowledge […]
As reported earlier this month, the Patented Medicine Prices Review Board has published a new draft of its guidelines and launched a 30-day written consultation period. While the law and regulations have already been passed, the implementation has been delayed from July 1, 2020 to Jan. 1, 2021. The new draft guidelines are in response […]
The federal government and several provinces are signing a new agreement regarding administration and regulation of multi-jurisdictional pension plans. The provincial governments of British Columbia, Alberta, Saskatchewan, Ontario, Quebec, New Brunswick and Nova Scotia are all on board with the agreement, which replaces the 2016 version, only signed by some provinces; a 1968 reciprocal agreement signed between all […]